135 related articles for article (PubMed ID: 24699354)
1. Obtaining fast dissolving disintegrating tablets with different doses of melatonin.
Muñoz H; Castan H; Clares B; Ruiz MA
Int J Pharm; 2014 Jun; 467(1-2):84-9. PubMed ID: 24699354
[TBL] [Abstract][Full Text] [Related]
2. Selection of generic preparations of famotidine orally disintegrating tablets for use in unit-dose packages.
Yamazaki N; Iizuka R; Miyazawa S; Wada Y; Shimokawa K; Ishii F
Drug Discov Ther; 2012 Oct; 6(5):263-8. PubMed ID: 23229147
[TBL] [Abstract][Full Text] [Related]
3. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
[TBL] [Abstract][Full Text] [Related]
4. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
5. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
6. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
Pabari RM; Ramtoola Z
Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
[TBL] [Abstract][Full Text] [Related]
7. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Jung HA; Augsburger LL
Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
[TBL] [Abstract][Full Text] [Related]
8. Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population.
Albertini B; Di Sabatino M; Melegari C; Passerini N
Int J Pharm; 2014 Jul; 469(1):67-79. PubMed ID: 24768728
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
10. In vitro determination of aceclofenac Mouth Dissolving Tablets.
Shobhit S; Gupta SK
Polim Med; 2013; 43(4):227-9. PubMed ID: 24596037
[TBL] [Abstract][Full Text] [Related]
11. Fast disintegrating tablets containing Rhodiola rosea L. extract.
Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
Kumar P; Singh I
Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
[TBL] [Abstract][Full Text] [Related]
13. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
Hooper P; Lasher J; Alexander KS; Baki G
J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
[TBL] [Abstract][Full Text] [Related]
14. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
[TBL] [Abstract][Full Text] [Related]
15. Effects of various excipients on tizanidine hydrochloride tablets prepared by direct compression.
Khan LG; Razvi N; Anjum F; Siddiqui SA; Ghayas S
Pak J Pharm Sci; 2014 Sep; 27(5):1249-54. PubMed ID: 25176379
[TBL] [Abstract][Full Text] [Related]
16. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
[TBL] [Abstract][Full Text] [Related]
17. Effect of powder characteristics on oral tablet disintegration.
Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
[TBL] [Abstract][Full Text] [Related]
18. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
19. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
20. [The use of semi-synthetic polymers in the formulation of sucking and chewable tablets containing sage extract and zinc gluconate].
Linka WA; Golenia E; Zgoda MM; Kołodziejczyk MK
Polim Med; 2014; 44(4):237-45. PubMed ID: 25932905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
